Cancer clinical trials in the region Pays de la Loire

215 currently recruiting clinical trials
Region Pays de la Loire

Phase 3 Lung cancer
#NCT06635824
NSCLC (Non-Small Cell Lung Cancer) Metastatic PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) 1 2 Immunotherapy Chemotherapy
ALK BRAF EGFR KRAS G12C KRAS non G12C MET RET ROS-1 Systemic Treatment-Naive Car-T
Hôpital Privé du Confluent - Vivalto Santé (Nantes), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier Universitaire Angers (Angers )
Genmab
Phase 3 Lung cancer
#NCT05170204
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced ALK Systemic Treatment-Naive
EGFR Immunotherapy Targeted therapy Immunotherapy Targeted therapy
Centre Hospitalier Universitaire Angers (Angers )
Hoffmann-La Roche
Phase 3 Lung cancer
#NCT06284317
NSCLC (Non-Small Cell Lung Cancer) Localized Locally Advanced None Systemic Treatment-Naive Systemic Treatment-Naive
ALK EGFR Surgery Immunotherapy Chemotherapy Surgery Immunotherapy Chemotherapy
Centre Hospitalier du Mans (Le Mans), Centre Hospitalier Universitaire Angers (Angers )
ETOP IBCSG Partners Foundation
Phase 3 Stomach and esophageal cancer
#NCT06346392
Stomach Oesogastric junction Esophagus Adenocarcinoma Locally Advanced Metastatic Claudin 18.2 1 2 3 or more Chemotherapy
HER2 Systemic Treatment-Naive
Centre Hospitalier Universitaire de Nantes (Nantes)
AstraZeneca
Phase 3 CLL & Richter's syndrome
#NCT05947851
CLL (Chronic Lymphocytic Leukemia) None Treated / Controled 1 2 3 or more
Systemic Treatment-Naive Targeted therapy
Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
Merck Sharp & Dohme LLC
Phase 3 Lung cancer
#NCT05555732
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced Metastatic PDL1 Negative (< 1%) PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) None Systemic Treatment-Naive
Immunotherapy Bispecific T-cell engager antibodies Antibody Drug Conjugates (ADC) Immunotherapy Bispecific T-cell engager antibodies Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Nantes (Nantes), Hôpital Privé du Confluent - Vivalto Santé (Nantes)
Daiichi Sankyo
Phase 3 Lung cancer
#NCT05899608
NSCLC (Non-Small Cell Lung Cancer) Squamous NSCLC Non-squamous NSCLC Metastatic Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier du Mans (Le Mans)
Summit Therapeutics
Phase 3 Lymphoma
#NCT05947851
B cell lymphoma Lymphocytic lymphoma None Treated / Controled 1 2 3 or more
Systemic Treatment-Naive Targeted therapy
Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
Merck Sharp & Dohme LLC
Phase 3 Prostate cancer
#NCT06120491
Metastatic Hormone-sensitive Surgery Radiotherapy Systemic Treatment-Naive
Centre Hospitalier Universitaire Angers (Angers )
AstraZeneca
Phase 3 Lung cancer
#NCT06623422
NSCLC (Non-Small Cell Lung Cancer) Localized Locally Advanced None Systemic Treatment-Naive Systemic Treatment-Naive
ALK EGFR Immunotherapy Immunotherapy
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Merck Sharp & Dohme LLC